Fight Cancer With Diet

ESTIMATE 4-MINUTE READ

William Li eloquently develops an answer to the question, “Can we eat to starve cancer?”

Controversial Diet Battle

Pin

In the final months, even a compas­sionate hug of her fragile frame brought pain. After a valiant fight lasting several years, a good friend succumbed to multiple myeloma. This is why a slide presented by Dr. Li at the TED2010 confer­ence caught my attention. Therein, a graph showed survival rates from this insidious form of cancer has improved 70% since 2004 with U.S. Food and Drug Administration (FDA) approved anti­angio­genic drugs.

Dr. William Li heads the Angiogenesis Foundation, a non­profit organiza­tion that is re-conceptualizing global disease fighting. In the U.S., there are currently eight approved anti-cancer therapies with recognized anti­angio­genic properties in oncology. The FDA has approved bevacizumab (Avastin®) for use with other drugs to treat colo­rectal cancer that has spread to other parts of the body, some non-small cell lung cancers, and some breast cancers that have spread to other parts of the body. Bevacizumab was the first angio­genesis inhibitor proven to delay tumor growth and, more impor­tantly, extend the lives of patients. The FDA has also approved other drugs with anti­angio­genic activity as cancer therapies for multiple myeloma, mantle cell lymphoma, gastro­intes­tinal stromal tumors (GIST), and kidney cancer.

LoginRemind

Join Discussion